OPA1 and Alzheimer disease: Previous studies have shown that OPA1 expression declines in AD patients and transgenic AD mouse model, and OPA1 overexpression can effectively alleviate Aβ1-42-induced mitochondrial damage and neuronal apoptosis [34-36].